It was reported a patient with a 25mm 11500a valve implanted in the aortic position developed a high gradient after an implant duration of approximately three years, eight months.The patient was placed back on doac medication for 8 weeks and will repeat tte at that time.Per information received: the patient doing well for three years on doac medications post avr.The patient stopped doac medications.The patient was off anticoagulation for the past 6 to 7 months.Doac medication restarted for 8 weeks and then repeat tte to see if gradients go down.If gradients do not decrease after restarting doac, be considered for viv.Not positive this is as; may be possibly laminated thrombus that developed while off anticoagulation past 6-7 months.Additional information received indicates that the patient underwent a tavr procedure and received a 26mm 9750tfx transcatheter valve.
|
H10: additional manufacturer narrative: the subject device is not available for evaluation, as it remains implanted in the patient.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
The device history record (dhr) review was completed, and this device passed all manufacturing and sterilization inspections prior to release for distribution.There were no issues identified that would have impacted this event.Engineering evaluation summary: high gradients can occur early or late in the lifetime of a prosthetic valve.When it occurs early after valve replacement, it is typically a result of pressure recovery, patient-prosthesis mismatch, and/or sub-valvular or supravalvular obstruction.Measurement error, a high-flow state, prosthesis dysfunction, and pannus overgrowth can cause late high gradients after aortic valve replacement.Prosthesis dysfunction is most likely related to patient/procedural factors, and not to manufacturing non-conformances, which most likely would be identified intraoperatively or early post implant.A definitive root cause cannot be conclusively determined; however, patient and factors likely caused or contributed.All pertinent information available to edwards lifesciences has been submitted.
|